These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 4539289

  • 1. [Chloroquine retinopathy].
    François J, de Rouck A, Cambie E, de Laey JJ.
    Ophthalmologica; 1972; 165(2):81-99. PubMed ID: 4539289
    [No Abstract] [Full Text] [Related]

  • 2. Long-term course of chloroquine retinopathy after cessation of medication.
    Brinkley JR, Dubois EL, Ryan SJ.
    Am J Ophthalmol; 1979 Jul; 88(1):1-11. PubMed ID: 463998
    [Abstract] [Full Text] [Related]

  • 3. Ocular effects and safety of antimalarial agents.
    Easterbrook M.
    Am J Med; 1988 Oct 14; 85(4A):23-9. PubMed ID: 3177429
    [Abstract] [Full Text] [Related]

  • 4. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1967 Oct 14; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography.
    Missner S, Kellner U.
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar 14; 250(3):319-25. PubMed ID: 22215255
    [Abstract] [Full Text] [Related]

  • 6. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C, Bechetoille A, Ebran JM.
    J Fr Ophtalmol; 1983 Mar 14; 6(8-9):689-95. PubMed ID: 6677659
    [Abstract] [Full Text] [Related]

  • 7. Complications of antimalarial therapy.
    Lozier JR, Friedlaender MH.
    Int Ophthalmol Clin; 1989 Mar 14; 29(3):172-8. PubMed ID: 2666332
    [No Abstract] [Full Text] [Related]

  • 8. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
    Tsang AC, Ahmadi S, Hamilton J, Gao J, Virgili G, Coupland SG, Gottlieb CC.
    Am J Ophthalmol; 2019 Oct 14; 206():132-139. PubMed ID: 31078540
    [Abstract] [Full Text] [Related]

  • 9. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine.
    Kellner U, Renner AB, Tillack H.
    Invest Ophthalmol Vis Sci; 2006 Aug 14; 47(8):3531-8. PubMed ID: 16877425
    [Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
    Browning DJ.
    Am J Ophthalmol; 2002 May 14; 133(5):649-56. PubMed ID: 11992862
    [Abstract] [Full Text] [Related]

  • 11. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK, Robinson M, Mandal N, Shah VA.
    Indian J Ophthalmol; 2015 Jul 14; 63(7):570-4. PubMed ID: 26458473
    [Abstract] [Full Text] [Related]

  • 12. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M, Chan EW, Omar A.
    Optom Vis Sci; 2018 Jun 14; 95(6):545-549. PubMed ID: 29787487
    [Abstract] [Full Text] [Related]

  • 13. Is corneal deposition of antimalarial any indication of retinal toxicity?
    Easterbrook M.
    Can J Ophthalmol; 1990 Aug 14; 25(5):249-51. PubMed ID: 2207871
    [Abstract] [Full Text] [Related]

  • 14. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF, Bhargava SK, Rosen ES.
    Invest Ophthalmol Vis Sci; 1989 Aug 14; 30(8):1726-31. PubMed ID: 2759787
    [Abstract] [Full Text] [Related]

  • 15. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS, Stiefelmeyer S, Berninger T, Arden GB, Rudolph G.
    Ophthalmic Res; 2004 Aug 14; 36(2):106-13. PubMed ID: 15017107
    [Abstract] [Full Text] [Related]

  • 16. [Chloroquine retinopathy. Peculiar behavior of the light sense].
    Stein R, Godel V, Nemet P.
    Klin Monbl Augenheilkd; 1972 Aug 14; 161(2):183-91. PubMed ID: 4638561
    [No Abstract] [Full Text] [Related]

  • 17. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan 14; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 18. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS, Saatci OA.
    Ann Ophthalmol; 1991 Aug 14; 23(8):290-1. PubMed ID: 1952637
    [Abstract] [Full Text] [Related]

  • 19. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
    Navajas EV, Krema H, Hammoudi DS, Lipton JH, Simpson ER, Boyd S, Easterbrook M.
    Can J Ophthalmol; 2015 Dec 14; 50(6):442-50. PubMed ID: 26651304
    [Abstract] [Full Text] [Related]

  • 20. Chloroquine retinopathy. Is fluorescein angiography necessary?
    Cruess AF, Schachat AP, Nicholl J, Augsburger JJ.
    Ophthalmology; 1985 Aug 14; 92(8):1127-9. PubMed ID: 4047606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.